Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Beretta

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
International Journal of Molecular Sciences|November 26, 2022
Nanostrategies: The Future Medicine for Fighting Cancer Progression and Drug Resistance 2.0Giovanni Luca Beretta
Current Medicinal Chemistry|July 20, 2023
Ferroptosis-induced Cardiotoxicity and Antitumor DrugsGiovanni Luca Beretta
International Journal of Molecular Sciences|February 24, 2024
Special Issue: "Novel Researches and Perspectives on Prostate Cancer"Giovanni Luca Beretta
Topics in Current Chemistry|April 23, 2013
Molecular mechanisms of anthracycline activityGiovanni Luca Beretta, Franco Zunino
Current Medicinal Chemistry|January 13, 2022
Ferroptosis Inducers for Prostate Cancer TherapyNadia Zaffaroni, Giovanni Luca Beretta
Biochemical Pharmacology|June 2, 2007
Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activityGiovanni Luca Beretta, Franco Zunino
Pharmaceutics|April 3, 2021
miRNAs as Therapeutic Tools and Biomarkers for Prostate CancerNoemi Arrighetti, Giovanni Luca Beretta
Pharmaceutics|November 27, 2021
Nanoparticles for Ferroptosis Therapy in CancerNadia Zaffaroni, Giovanni Luca Beretta
Cells|April 12, 2022
Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic PotentialGiovanni Luca Beretta, Nadia Zaffaroni
Expert Opinion on Therapeutic Targets|September 11, 2008
Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitorsGiovanni Luca Beretta, Paola Perego, Franco Zunino
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
International Journal of Molecular Sciences|November 26, 2022
Nanostrategies: The Future Medicine for Fighting Cancer Progression and Drug Resistance 2.0Giovanni Luca Beretta
Current Medicinal Chemistry|July 20, 2023
Ferroptosis-induced Cardiotoxicity and Antitumor DrugsGiovanni Luca Beretta
International Journal of Molecular Sciences|February 24, 2024
Special Issue: "Novel Researches and Perspectives on Prostate Cancer"Giovanni Luca Beretta
Topics in Current Chemistry|April 23, 2013
Molecular mechanisms of anthracycline activityGiovanni Luca Beretta, Franco Zunino
Current Medicinal Chemistry|January 13, 2022
Ferroptosis Inducers for Prostate Cancer TherapyNadia Zaffaroni, Giovanni Luca Beretta
Biochemical Pharmacology|June 2, 2007
Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activityGiovanni Luca Beretta, Franco Zunino
Pharmaceutics|April 3, 2021
miRNAs as Therapeutic Tools and Biomarkers for Prostate CancerNoemi Arrighetti, Giovanni Luca Beretta
Pharmaceutics|November 27, 2021
Nanoparticles for Ferroptosis Therapy in CancerNadia Zaffaroni, Giovanni Luca Beretta
Cells|April 12, 2022
Necroptosis and Prostate Cancer: Molecular Mechanisms and Therapeutic PotentialGiovanni Luca Beretta, Nadia Zaffaroni
Expert Opinion on Therapeutic Targets|September 11, 2008
Targeting topoisomerase I: molecular mechanisms and cellular determinants of response to topoisomerase I inhibitorsGiovanni Luca Beretta, Paola Perego, Franco Zunino
Pageof 6